Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Guangdong General Hospital
Sponsor:
Information provided by (Responsible Party):
Guangdong General Hospital
ClinicalTrials.gov Identifier:
NCT02059876
First received: February 7, 2014
Last updated: February 11, 2014
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)